Home›Stock Screener›IOL Chemicals & Pharmaceuticals

IOL Chemicals & Pharmaceuticals Share Price Today | Stock Price & IOL Chemicals & Pharmaceuticals Share Screener

IOLCP Pharmaceuticals & Biotechnology
Live Share Price NSE
₹189.74
▼ -1.00 (-0.52%)
2026-11-18 00:00:00
Live Share Price BSE
₹189.90
▼ -0.75 (-0.39%)
2026-11-18 00:00:00

As of November 18, 2026, the live IOL Chemicals & Pharmaceuticals share price (NSE: IOLCP) is ₹189.74 on NSE and ₹189.90 on BSE, down 0.52% from the previous close, with shares trading between ₹186.03 and ₹192.55 in today's trading session, and a 52-week range of ₹68.21–₹220.22. Track IOLCP market cap trends to gauge the company's total market size. Use the IOL Chemicals & Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today IOL Chemicals & Pharmaceuticals opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹621 and net income of ₹53, with EBITDA of ₹94, an operating margin of 15.0% and a profit margin of 8.5%.

IOL Chemicals & Pharmaceuticals Market Cap ₹5,918.40 Cr.
IOLCP P/E Ratio (TTM) 29.60
IOL Chemicals & Pharmaceuticals P/B Ratio 3.12
EPS (TTM) ₹4.69
Dividend Yield 0.49%
Debt to Equity 0.07
IOLCP 52 Week High ₹220.22
IOL Chemicals & Pharmaceuticals 52 Week Low ₹68.21
Operating Margin 15.00%
Profit Margin 8.53%
IOLCP Revenue (TTM) ₹621.00
EBITDA ₹94.00
Net Income ₹53.00
Total Assets ₹2,587.00
Total Equity ₹1,799.00

IOL Chemicals & Pharmaceuticals Share Price Chart

Track the current stock price of IOL Chemicals & Pharmaceuticals with an interactive chart. Analyse IOLCP share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete IOL Chemicals & Pharmaceuticals stock quote in one place.

The quote of ₹189.74 sits between the 52-week low of ₹68.21 and the 52-week high of ₹220.22, and the latest session moved -0.52% from the previous close.

IOL Chemicals & Pharmaceuticals Company Profile - Fundamental Screener

Screen IOL Chemicals & Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for IOLCP shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE485C01029.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE485C01029

IOL Chemicals & Pharmaceuticals Balance Sheet Screener

Screen IOLCP balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹2,587, up from ₹2,382 in 2025.

Latest statistics put total assets at ₹2,587 and shareholder funds at ₹1,799, with a leverage ratio of 0.07.

Item 2026 2025 2024 2023 2022

Assets

Total Assets 2,587 2,382 2,244 2,022 1,962
Current Assets 0 0 0 0 0
Fixed Assets 1,182 1,171 933 752 561

Liabilities

Total Liabilities 0 0 0 0 0
Current Liabilities 98 85 73 58 57
Non-Current Liabilities 0 0 0 0 0

Shareholders' Equity

Total Equity 1,799 1,688 1,612 1,508 1,392
Share Capital 59 59 59 59 59
Reserves & Surplus 1,740 1,629 1,553 1,449 1,334

IOL Chemicals & Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis

Screen IOL Chemicals & Pharmaceuticals income statement and profit fundamentals. Analyze IOLCP quarterly results. IOL Chemicals & Pharmaceuticals reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹621 and net profit was ₹53, equal to earnings per unit of ₹1.81, at an operating margin of 15%.

In that period expenses were ₹527, interest cost ₹3 and tax ₹18. The next period listed, 2026-Jun, shows revenue of ₹764 and net profit of ₹64.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec

Revenue and Expenses

Revenue 621 764 801 532 559 574 586 511 510 532 527 596 570 552 529
Expenses 527 653 686 465 490 511 534 454 451 484 476 492 491 481 476

Operating Costs and Margins

EBITDA 94 112 115 67 70 64 51 57 59 48 51 104 80 71 53
Operating Profit % 15.00% 14.00% 14.00% 12.00% 11.00% 10.00% 8.00% 10.00% 10.00% 8.00% 9.00% 16.00% 13.00% 12.00% 9.00%
Depreciation 20 21 22 19 20 20 20 16 17 18 19 12 14 16 16
Interest 3 4 5 4 4 4 4 3 2 4 5 5 4 4 4

Profit and Earnings

Profit Before Tax 71 87 87 45 46 41 28 37 40 26 28 87 61 51 32
Tax 18 22 22 13 12 11 7 10 10 7 7 22 15 13 9
Net Profit 53 64 65 31 34 30 21 28 30 19 21 65 46 38 23
EPS 1.81 2.19 2.22 1.07 1.16 1.02 0.70 4.71 5.11 3.26 3.50 11.03 7.81 6.45 3.93

IOL Chemicals & Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals

Screen IOLCP cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹214, and net cash flow was an outflow of ₹13.

Over the same period, investing activities used ₹198 and financing activities used ₹29.

Item 2026-March 2025-March 2024-March 2023-March 2022-March

Cash from Operations and Investing

Operating Activities 214 179 290 122 93
Investing Activities -198 -154 -191 -120 -121

Financing and Net Cash

Financing Activities -29 46 -93 -4 -2
Net Cash Flow -13 71 6 -2 -29

IOL Chemicals & Pharmaceuticals Shareholding Pattern Screener

See IOL Chemicals & Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings. Check IOL Chemicals & Pharmaceuticals promoter holding and ownership changes for IOLCP on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Sept, promoters held 62.28%, foreign institutions 7.25%, domestic institutions 0.30% and the public 25.88%, spread across 132,241 shareholders.

The shareholder count was 132,241 in 2026-Sept, compared with 119,311 in 2026-Jun.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec

Promoter Holding

Promoter Holding 62.28% 62.28% 57.48% 52.62% 52.62% 52.62% 52.62% 52.62%

Institutional Investors

FII Holding 7.25% 4.87% 1.72% 2.08% 2.25% 2.59% 1.47% 1.49%
DII Holding 0.30% 0.43% 0.02% 0.03% 0.04% 0.02% 0.07% 0.08%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 25.88% 26.95% 31.03% 30.51% 29.97% 30.22% 31.43% 31.23%
Other Holding 4.29% 5.47% 9.74% 14.76% 15.12% 14.54% 14.40% 14.58%
Shareholder Count 132,241 119,311 131,550 133,531 136,129 125,040 130,002 126,701

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by IOL Chemicals & Pharmaceuticals. IOL Chemicals & Pharmaceuticals dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹1.00 per unit for 2026-March, a yield of 0.50%, compared with ₹0.80 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹1.00, ₹0.80 and ₹5.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹1.00 0.50%
2025-March ₹0.80 1.10%
2024-March ₹5.00 8.18%
2023-March ₹4.00 5.53%
2022-March ₹4.00 7.07%
2021-March ₹6.00 8.48%
2020-March ₹3.00 2.72%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

IOL Chemicals & Pharmaceuticals Stock Index Membership - Nifty & Sensex

See which indices include IOL Chemicals & Pharmaceuticals stock. Check IOLCP index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 3 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP

IOL Chemicals & Pharmaceuticals Market Events Screener - Corporate Actions

Get IOL Chemicals & Pharmaceuticals corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check IOL Chemicals & Pharmaceuticals stock events that may affect IOLCP share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated October 30, 2026, with a record date of October 30, 2026.

It is followed by Annual General Meeting dated September 2, 2026 and Quarterly Result Announcement dated August 10, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-10-30 2026-10-30 Quarterly Result Announcement NA 7.87%
2026-09-02 2026-09-02 Annual General Meeting NA 72.83%
2026-08-10 2026-08-10 Quarterly Result Announcement NA 14.67%
2026-05-20 2026-05-20 Quarterly Result Announcement NA 4.26%
2026-02-17 2026-02-17 Dividend ₹ 1.00 /share -7.50%
2026-02-11 2026-02-11 Quarterly Result Announcement NA 12.36%
2025-11-11 2025-11-11 Quarterly Result Announcement NA -5.32%
2025-08-22 2025-08-22 Annual General Meeting NA 27.43%
2025-08-07 2025-08-07 Quarterly Result Announcement NA 0.92%
2025-05-16 2025-05-16 Quarterly Result Announcement NA 18.62%
2025-03-11 2025-03-11 Split 2:10 -16.00%
2025-02-18 2025-02-18 Dividend ₹ 4.00 /share -7.33%
2025-02-12 2025-02-12 Quarterly Result Announcement NA 1.31%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -6.34%
2024-08-23 2024-08-23 Annual General Meeting NA 24.87%

IOL Chemicals & Pharmaceuticals Competitors Screener - Peer Stocks Comparison

Screen IOLCP competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 451,075 41.20 61,674 12.69% 11,565 63.60
Divis Laboratories 303,749 90.40 11,067 13.95% 2,568 78.53
Torrent Pharmaceuticals 177,632 85.50 13,886 20.34% 2,138 47.27
Laurus Labs 130,972 97.10 6,868 22.01% 890 69.60
Zydus Life Science 118,693 28.00 27,658 17.64% 5,026 52.34
Dr Reddys Laboratories 115,186 42.00 35,059 3.90% 4,158 70.24
Cipla 112,438 39.90 29,045 2.24% 3,870 54.92
Mankind Pharma 109,044 48.10 14,636 14.85% 1,938 65.43
Aurobindo Pharma 104,903 26.00 34,145 5.56% 3,503 66.06
Lupin 90,557 17.60 29,039 26.75% 5,356 44.92

IOL Chemicals & Pharmaceuticals Company Announcements - News & Reports Screener

Screen IOLCP latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 15, 2026.

The next most recent announcements are dated November 15, 2026 and November 9, 2026.

Date Update Actions
2026-11-15 Clarification On Increase In Volume -
2026-11-15 Clarification sought from IOL Chemicals & Pharmaceuticals Ltd -
2026-11-09 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-11-02 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-11-02 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-11-02 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-10-30 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-10-30 Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Unaudited Financial Results Of The Company For The Quarter And Half Year Ended 30Th September 2026 -
2026-10-30 Outcome Of The Board Meeting And Submission Of Unaudited Financial Results Of The Company For The Quarter And Half Year Ended 30Th September 2026 -
2026-10-28 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-10-23 Board Meeting Intimation for Notice Of Board Meeting -
2026-10-17 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-10-07 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-25 Grant Of Certificate Of Suitability (CEP) For Fenofibrate - Process II -
2026-09-25 Closure of Trading Window -
2026-09-23 EU-REACH Registration For Triacetin -
2026-09-23 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-23 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-21 Dispatch Of Reminder Letter To Shareholders To Update KYC -
2026-09-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹189.74, within a 52-week range of ₹68.21 to ₹220.22. The P/E ratio is 29.60 and the P/B ratio is 3.12, with earnings per unit of ₹4.69. Market capitalisation stands at ₹5,918.40 Cr and the dividend yield is 0.49%. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 19, 2026. This page covers 5 balance sheet periods, 15 income statement periods, 5 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.